Table II.

Incomplete vaccination among employees by self-reported allergic symptoms after dose one of mRNA COVID-19 vaccination

Incomplete vaccination	No self-reported allergic symptoms (OR, 95% CI)	Any self-reported allergic symptoms after dose 1 (OR, 95% CI)	P value
Number of events	305	43
Unadjusted	1.00 (reference)	5.68 (4.11-7.85)	<.001
Adjusted∗	1.00 (reference)	5.15 (3.75-7.06)	<.001

Incomplete vaccination	No self-reported allergic symptoms (OR, 95% CI)	Severe self-reported allergic symptoms after dose one (OR, 95% CI)	P value
Number of events	305	6
Unadjusted	1.00 (reference)	23.2 (9.7-55.2)	<.001

^∗Multivariable model adjusted for age, sex, race, vaccine manufacturer, MGB site, wave of vaccine eligibility.